Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-24 @ 11:52 PM
NCT ID:
NCT02891551
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years of age who understand and voluntarily sign an informed consent form.
* Patients who are treated with azacitidine in accordance with registered indication and clinical practice.
Exclusion Criteria:
* Refusal to participate in the study.
* Participation in an interventional clinical study.
* Patients previously treated with azacitidine except when given as induction therapy for a maximum of three courses.
* Women who are pregnant or breast-feeding.
* Hypersensitivity to the active substance or to any of the excipients.
* Advanced malignant hepatic tumors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02891551
Study Brief:
Protocol Section:
NCT02891551